GLS and melanoma: In contrast, KGA expression is unchanged by actinomycin D before and after treatment of CDK4/6i in NrasQ61R skmel2 cells (Fig. 1G), demonstrating the specificity of KGA upregulation in BrafV600E melanoma cells.